Manipal Health Enterprises Limited IPO: Issue Price, Listing Gain and Share Price Now
Manipal Health Enterprises Limited listed on 05-Aug-2026 at ₹666.7 against an issue price of ₹590 , a listing gain of +13.00%. It last traded at ₹741.05 (25-Aug-2026). This page is the record of that issue and what has happened to it since — reported figures only.
Manipal Health Enterprises Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹590 |
| Listing price (listing-day close) | ₹666.7 |
| Listing gain | +13.00% |
| Price now | ₹741.05 |
| Change from issue price | +25.60% |
| Change from listing-day close | +11.15% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Manipal Health Enterprises Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹590 |
| Issue size | ₹9,275.22 Cr |
| Fresh issue | ₹8,000.22 Cr |
| Offer for sale | ₹1,275 Cr |
| Issue opened | 29-Jul-2026 |
| Issue closed | 31-Jul-2026 |
| Listed on | 05-Aug-2026 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | Kotak Mahindra Capital (left lead) |
How the Manipal Health Enterprises Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 8.54x |
| NII | 1.06x |
| Retail | 0.98x |
| Total | 5.12x |
Manipal Health Enterprises Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹95,311 Cr |
| Trailing P/E | 108.00x |
| Return on capital employed | 12.1% |
| Return on equity | 12.7% |
| 52-week high | ₹758 |
| 52-week low | ₹625 |
| Sector | Hospital |
Fundamentals are as of the desk's last harvest and move with the market.
- Manipal Health Enterprises Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.